|

WAMIF: Prospective Study in Young Women Presenting Acute Myocardial Infarction: Cohort Follow up

RECRUITINGSponsored by French Cardiology Society
Actively Recruiting
SponsorFrench Cardiology Society
Started2025-11-25
Est. completion2029-09-30
Eligibility
Age18 Years – 60 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07181317

Summary

The WAMIF study was conducted from 2017 to 2019, including 314 patients in 30 French research centers spread across metropolitan France. It systematically collected the clinical, morphological, and biological characteristics of myocardial infarction cases affecting women under 50 years of age and assessed their short-term (in-hospital) and medium-term (12-month) prognosis. Extending the follow-up beyond 12 months for this first study would provide fundamental data for understanding and improving the care of these patients.

Eligibility

Age: 18 Years – 60 YearsSex: FEMALEHealthy volunteers accepted
All patients who participated in the WAMIF study (research registration number with the French Ministry of Health : 2015-A01263-46 / Protocol registration with Clinical Trials NCT03073447) and wish to continue follow-up in the study.

Conditions2

Heart DiseaseMyocardial Infarction, Acute

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.